Radiation Oncology, Treatment Protocols
Esophageal, Esophageal Metastatic, Gastrointestinal, Stomach, Stomach Metastatic
A Phase III Study of Consolidative Radiotherapy in Patients with Oligometastatic HER2 Negative Esophageal and Gastric Adenocarcinoma (EGA)
Eligible for screening study DCP 001
EA2183 is temporarily suspended to new accrual, effective 06/15/21.